Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIK066 for Weight Loss in Obese Patients
NCT02470403Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of licogliflozin in obesity, sponsored by Novartis. Started Jun 2015; status: completed.
02
Drugs
licogliflozin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02470403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470403.